The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A look back: Results from 1 year of routine clinical testing of both hematologic and solid tumors using two targeted next-generation sequencing (NGS) panels.
Robert D Daber
Honoraria - Illumina
Corey J. Langer
No relevant relationships to disclose
Selina M. Luger
No relevant relationships to disclose
Lynn Mara Schuchter
No relevant relationships to disclose
D. Gary Gilliland
No relevant relationships to disclose
David Roth
No relevant relationships to disclose
Martin Carroll
No relevant relationships to disclose
Katherine L. Nathanson
No relevant relationships to disclose
Jennifer J. Morrissette
No relevant relationships to disclose